Directory
>
Pietro Taverna
Pietro Taverna
Vice President Research & Translational Medicine | Karyopharm Therapeutics Inc.
Waltham, Massachusetts, United States
Pietro Taverna
Summary
Pietro Taverna is a distinguished Vice President of Research & Translational Medicine, with extensive expertise in the biopharmaceutical sector, particularly in oncology and translational research. He has a proven track record of leading cross-functional teams through all phases of drug development, from discovery to late-stage clinical trials. His collaborative approach has fostered significant partnerships within the academic and industrial landscapes, enhancing drug development processes. Pietro is highly regarded for his strategic insights in pharmacology and biomarker discovery, and has contributed to numerous publications in prestigious journals. His leadership has driven innovation in translational medicine, particularly in the development of therapies for hematologic malignancies. With a strong educational background in pharmacology, he combines scientific rigor with practical experience to advance therapeutic solutions. Beyond his professional achievements, he has received notable fellowships, underscoring his commitment to excellence in research.
Pietro Taverna
Work Experience
Vice President Research & Translational Medicine at
Karyopharm Therapeutics Inc.
February 2023 - Present
Executive Director, Translational Sciences at
MorphoSys AG
May 2021 - February 2023
Vice President, Translational Medicine & Nonclinical Development at
Sunesis Pharmaceuticals, Inc.
November 2019 - January 2021
Executive Director, Translational Medicine at
Sunesis Pharmaceuticals, Inc.
March 2017 - November 2019
Senior Director, Translational Pharmacology at
Astex Pharmaceuticals, Inc. (US)
April 2014 - February 2017
Director Translational Pharmacology at
Astex Pharmaceuticals, Inc. (US)
June 2011 - April 2014
Assoc. Director, Translational Pharmacology at
Astex Pharmaceuticals, Inc. (US)
August 2008 - June 2011
Senior Scientist, Pharmacology at
Sunesis Pharmaceuticals, Inc.
July 2006 - August 2008
Principal Scientist, Pharmacology at
Chiron Corporation
March 2003 - July 2006
Scientist at
PANGENE CORPORATION
March 2001 - February 2003
Pietro Taverna
Education
Case Western Reserve University, Research Associate Scientist
January 1997 - January 2001
Imperial Cancer Research Fund, London, UK, Postdoctoral Fellow
January 1992 - January 1995
Istituto Mario Negri, Milan, Italy, Pharmacological Research (Phd)
January 1990
University of Milan, Biological Sciences (Laurea)
January 1987
Frequently Asked Questions about Pietro Taverna
What is Pietro Taverna email address?
Pietro Taverna's primary email address is **************@constellationpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Pietro Taverna work for?
Pietro Taverna is a Vice President Research & Translational Medicine at Karyopharm Therapeutics Inc., a company specializing in Biological products, except diagnostic.
Where Pietro Taverna graduated from?
Pietro Taverna holds a degree in from Case Western Reserve University.
How can I directly contact Pietro Taverna?
To contact Pietro Taverna directly, you can use the email address **************@constellationpharma.com. Complete contact information is available upon registration with Muraena.
Is Pietro Taverna an immigrant?
Yes, Pietro Taverna is an immigrant and currently based in United States
Who is Pietro Taverna?
Pietro Taverna is a distinguished Vice President of Research & Translational Medicine, with extensive expertise in the biopharmaceutical sector, particularly in oncology and translational research. He has a proven track record of leading cross-functional teams through all phases of drug development, from discovery to late-stage clinical trials. His collaborative approach has fostered significant partnerships within the academic and industrial landscapes, enhancing drug development processes. Pietro is highly regarded for his strategic insights in pharmacology and biomarker discovery, and has contributed to numerous publications in prestigious journals. His leadership has driven innovation in translational medicine, particularly in the development of therapies for hematologic malignancies. With a strong educational background in pharmacology, he combines scientific rigor with practical experience to advance therapeutic solutions. Beyond his professional achievements, he has received notable fellowships, underscoring his commitment to excellence in research.
Pietro`s contact details
**************@constellationpharma.com
**************@astx.com
**************@karyopharm.com
Colleagues
Vice President, Data Sciences
Independent Board Director
Lecturer, Graduate Program (Regulatory Affairs)
Vice President, Business Operations and Corporate Affairs
Executive Director - Head of Medical Strategy Global Medical and Scientific Affairs
Vice President of Market Access
Vice President, Clinical Pharmacology
Vice President, Program Lead - Oncology
Vice President, Clinical Development - Myelofibrosis and MDS
Vice President, Regulatory Affairs